These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 12678358

  • 1. Bone mineral density in long-term survivors of highly malignant osteosarcoma.
    Holzer G, Krepler P, Koschat MA, Grampp S, Dominkus M, Kotz R.
    J Bone Joint Surg Br; 2003 Mar; 85(2):231-7. PubMed ID: 12678358
    [Abstract] [Full Text] [Related]

  • 2. Do Patients After Chondrosarcoma Treatment Have Age-appropriate Bone Mineral Density in the Long Term?
    Hobusch GM, Tiefenboeck TM, Patsch J, Krall C, Holzer G.
    Clin Orthop Relat Res; 2016 Jun; 474(6):1508-15. PubMed ID: 26883654
    [Abstract] [Full Text] [Related]

  • 3. Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.
    Müller C, Winter CC, Rosenbaum D, Boos J, Gosheger G, Hardes J, Vieth V.
    BMC Musculoskelet Disord; 2010 Dec 29; 11():287. PubMed ID: 21190557
    [Abstract] [Full Text] [Related]

  • 4. Is There an Association Between Bone Microarchitecture and Fracture in Patients who were Treated for High-grade Osteosarcoma? A Controlled Study at Long-term Follow-up Using High-resolution Peripheral Quantitative CT.
    Holzer G, Hobusch G, Hansen S, Fischer L, Patsch JM.
    Clin Orthop Relat Res; 2021 Nov 01; 479(11):2493-2501. PubMed ID: 34077400
    [Abstract] [Full Text] [Related]

  • 5. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Hong AR, Kim JH, Lee KH, Kim TY, Im SA, Kim TY, Moon HG, Han WS, Noh DY, Kim SW, Shin CS.
    Osteoporos Int; 2017 Apr 01; 28(4):1413-1422. PubMed ID: 28083668
    [Abstract] [Full Text] [Related]

  • 6. Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.
    Pirker-Frühauf UM, Friesenbichler J, Urban EC, Obermayer-Pietsch B, Leithner A.
    Clin Orthop Relat Res; 2012 Oct 01; 470(10):2874-85. PubMed ID: 22806259
    [Abstract] [Full Text] [Related]

  • 7. The prevalence of significant left-right differences in hip bone mineral density.
    Hamdy R, Kiebzak GM, Seier E, Watts NB.
    Osteoporos Int; 2006 Dec 01; 17(12):1772-80. PubMed ID: 17019523
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R, Austrian Breast and Colorectal Cancer Study Group (ABCSG).
    Lancet Oncol; 2008 Sep 01; 9(9):840-9. PubMed ID: 18718815
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA, Nair V.
    Arch Osteoporos; 2012 Sep 01; 7():147-53. PubMed ID: 23225292
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density deficits in pediatric patients treated for sarcoma.
    Kaste SC, Ahn H, Liu T, Liu W, Krasin MJ, Hudson MM, Spunt SL.
    Pediatr Blood Cancer; 2008 May 01; 50(5):1032-8. PubMed ID: 17570705
    [Abstract] [Full Text] [Related]

  • 11. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
    Howell SJ, Radford JA, Adams JE, Shalet SM.
    Clin Endocrinol (Oxf); 2000 May 01; 52(5):609-16. PubMed ID: 10792341
    [Abstract] [Full Text] [Related]

  • 12. Young age at diagnosis, male sex, and decreased lean mass are risk factors of osteoporosis in long-term survivors of osteosarcoma.
    Lim JS, Kim DH, Lee JA, Kim DH, Cho J, Cho WH, Lee SY, Jeon DG.
    J Pediatr Hematol Oncol; 2013 Jan 01; 35(1):54-60. PubMed ID: 23128330
    [Abstract] [Full Text] [Related]

  • 13. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
    Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J.
    AIDS; 2003 Sep 05; 17(13):1917-23. PubMed ID: 12960824
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors.
    Kang MJ, Kim SM, Lee YA, Shin CH, Yang SW, Lim JS.
    Osteoporos Int; 2012 Jul 05; 23(7):1921-9. PubMed ID: 22057549
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density in Iranian patients with inflammatory bowel disease.
    Zali M, Bahari A, Firouzi F, Daryani NE, Aghazadeh R, Emam MM, Rezaie A, Shalmani HM, Naderi N, Maleki B, Sayyah A, Bashashati M, Jazayeri H, Zand S.
    Int J Colorectal Dis; 2006 Dec 05; 21(8):758-66. PubMed ID: 16463035
    [Abstract] [Full Text] [Related]

  • 16. Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH-deficient adults.
    Clanget C, Seck T, Hinke V, Wüster C, Ziegler R, Pfeilschifter J.
    Clin Endocrinol (Oxf); 2001 Jul 05; 55(1):93-9. PubMed ID: 11453957
    [Abstract] [Full Text] [Related]

  • 17. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
    Böttcher J, Pfeil A, Lehmann G, Heinrich B, Malich A, Hansch A, Petrovitch A, Mentzel HJ, Hein G, Kaiser WA.
    Z Rheumatol; 2004 Dec 05; 63(6):473-82. PubMed ID: 15605213
    [Abstract] [Full Text] [Related]

  • 18. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
    Dubois EF, Röder E, Dekhuijzen PN, Zwinderman AE, Schweitzer DH.
    Chest; 2002 May 05; 121(5):1456-63. PubMed ID: 12006428
    [Abstract] [Full Text] [Related]

  • 19. The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis.
    Kume K, Amano K, Yamada S, Kanazawa T, Ohta H, Hatta K, Amano K, Kuwaba N.
    Rheumatology (Oxford); 2014 May 05; 53(5):900-3. PubMed ID: 24441151
    [Abstract] [Full Text] [Related]

  • 20. The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.
    Hämäläinen H, Kautiainen H, Kaarela K, Kotaniemi A.
    Clin Exp Rheumatol; 2005 May 05; 23(2):193-8. PubMed ID: 15895889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.